Unleash the full potential of higher throughput genotoxicity assays [WEBINAR]

Miltenyi Biotec and Litron Laboratories review semi-automated products and procedures that combine instrumentation and kits for in vitro micronucleus assessment and additional flow cytometry-based kits evaluating multiple endpoints of DNA damage to deliver information on compound characterization and genotoxic mode of action. Simultaneously, we demonstrate how to conduct content-rich analyses whilst keeping to the three Rs of research: replacement, reduction, and refinement.

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover the techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our more than 25 years’ expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 2,800 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.